IDL Diagnostics attended the European Association of Urology (EAU) 2026 conference in London last week. We had valuable discussions with physicians who use our diagnostic biomarkers in clinical practice and research. A big thank you to everyone we met at EAU26! We...
News
Latest news.
Presentation of IDL Diagnostics Interim Report Q4 2025
CEO Anders Hultman and CFO Ellen Dittberner present the company’s Q4’25 results – February 26, 2026 Q4 Interview: Redeye talks with CEO Anders Hultman
IDL Diagnostics and concile at WHX Labs Dubai
Last week, IDL Diagnostics participated as an exhibitor at WHX Labs Dubai together with concile as part of the recently announced joint venture. The main focus is on delivering multiple biomarkers across different POC reader configurations and supporting infection,...
Meet us at WHX Labs Dubai 10-13 February
We will be co-exhibiting together with our partner concile at Booth SA.A55. Come by our booth and learn more about our products and how quantitative point-of-care testing can be used to provide accurate and rapid results.
IDL Diagnostics participates at RedEye Theme Event Fight Cancer
On January 21st Redeye hosted a Fight Cancer 2026 theme event where CEO Anders Hultman presented about the company, market opportunities and the new strategic priority. See the presentation here
Strategy update: IDL Diagnostics
A strategy update with IDL Diagnostics was held on November 27th at Redeye, where CEO Anders Hultman and the management team presented recent achievements, spotlighted key initiatives, and discussed future opportunities looking toward 2026 and beyond. After their...
Meet us at Medica 17-20 November
IDL Diagnostics will be exhibiting on of the largest medical trade fairs in the works, Medica Dusseldorf starting November 17-20. Visit Gustav Sten, Xia Jiang and Anders Hultman at Hall1, Booth H69
Presentation of IDL Diagnostics Interim Report Q3 2025
Redeye interview with Anders Hultman CEO, commenting on the Interim Report Q3 2025 IDL Diagnostics (Q3 Interview): Redeye talks with CEO Anders Hultman IDL Diagnostics: CEO Anders Hultman and CFO Ellen Dittberner present the company’s Q3’25 results – November...
Thesis projects at IDL Diagnostics.
We are pleased to recognize four outstanding students who have recently completed their thesis projects with us at IDL Diagnostics. The projects started in January 2025. Putri Rezqita and Yu Shi from Karolinska Institutet contributed their deep knowledge in health and...
IDL Diagnostics strengthens its presence in Indonesia through the SISP partnership
Last week, IDL Diagnostics participated in the Sweden-Indonesia Sustainability Partnership (SISP) 2025, organized by Business Sweden and the Swedish Embassy in Indonesia. The Sweden-Indonesia Sustainability Partnership (SISP) is a platform designed to foster...







